ARCHITECT TOXO IGG
Report
- Report Number
- 3002809144-2025-00357
- Event Type
- Malfunction
- Date Received
- November 10, 2025
- Date of Event
- September 25, 2025
- Report Date
- December 8, 2025
- Manufacturer
- ABBOTT GMBH
- Product Code
- LGD
- UDI-DI
- 00380740009205
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AR
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE COMPLAINT INVESTIGATION OF LOT: 71072BE00 INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TICKET TRENDING REVIEW, LABELING REVIEW, DEVICE HISTORY RECORD REVIEW, AND FIELD DATA REVIEW. DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE WITHOUT INDICATION FOR ANY ADDITIONAL ISSUE. THE TICKET SEARCH BY LOT INDICATES THAT THE REAGENT LOT PERFORMS AS EXPECTED FOR THIS PRODUCT. TICKET TRENDING REVIEW FOR THE LIST NUMBER DID NOT IDENTIFY ANY RELATED TRENDS. DEVICE HISTORY REVIEW DID NOT IDENTIFY ANY NON-CONFORMANCE'S OR DEVIATIONS WITH THE COMPLAINT LOT. THE OVERALL PERFORMANCE OF THE ARCHITECT TOXO IGG REAGENTS IN THE FIELD WAS REVIEWED USING DATA GATHERED FROM CUSTOMERS WORLDWIDE. THE PATIENT MEDIAN VALUES OBTAINED WITH THE COMPLAINT LOT: 71072BE00 IS WITHIN ESTABLISHED LIMITS AND COMPARABLE TO THE HISTORICAL LOT PERFORMANCE. LABELING WAS REVIEWED AND SUFFICIENTLY ADDRESSES THE CUSTOMER¿S ISSUE. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ARCHITECT TOXO IGG REAGENT LOT: 71072BE00 WAS IDENTIFIED.
AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 06C19-25 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 6C19, WITH 510K/PMA/BLA NUMBER K210596.
THE CUSTOMER REPORTED A FALSE REACTIVE ARCHITECT TOXO IGG RESULT GENERATED ON THE ARCHITECT I1000SR ANALYZER FOR ONE PATIENT SAMPLE. THE FOLLOWING DATA WAS PROVIDED: TESTED ON (B)(6) 2025, SID: (B)(6): TOXO IGG RESULT = 5.5 IU/ML (REACTIVE); REPEAT RESULT = 0.2 IU/ML (NONREACTIVE). THIS PATIENT SAMPLE WAS INITIALLY HEMOLYZED AND THE REPEAT RESULT WAS TESTED ON A NEW SAMPLE TAKEN FROM THE PATIENT. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
THE CUSTOMER REPORTED A FALSE REACTIVE ARCHITECT TOXO IGG RESULT GENERATED ON THE ARCHITECT I1000SR ANALYZER FOR ONE PATIENT SAMPLE. THE FOLLOWING DATA WAS PROVIDED: TESTED ON (B)(6) 2025, SID (B)(6): TOXO IGG RESULT = 5.5 IU/ML (REACTIVE); REPEAT RESULT = 0.2 IU/ML (NONREACTIVE). THIS PATIENT SAMPLE WAS INITIALLY HEMOLYZED AND THE REPEAT RESULT WAS TESTED ON A NEW SAMPLE TAKEN FROM THE PATIENT. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 311549 | ARCHITECT TOXO IGG | ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII | LGD | ABBOTT GMBH | 71072BE00 | 00380740009205 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | ARC I1000SR MOD, 01L86-01, I1SR54786.| ARC I1000SR MOD, 01L86-01, I1SR54786. |